Literature DB >> 14999396

[Treatment of acute respiratory distress syndrome in a treatment center. Success is dependent on risk factors].

D Henzler1, R Dembinski, R Kopp, R Hawickhorst, R Rossaint, R Kuhlen.   

Abstract

SUBJECT: Mortality rates remain high for the acute respiratory distress syndrome (ARDS) despite standardised treatment algorithms. Little is known about prognostic factors and exclusion criteria for advanced treatment including extracorporeal membrane oxygenation (ECMO).
METHODS: In an observational study design a cohort of 93 patients with severe ARDS admitted to a referral centre were analysed according to ventilatory and vital parameters.
RESULTS: Overall survival rate was 70% and in patients who received ECMO treatment it was 67%. In patients exhibiting relevant co-morbidity the odds ratio for fatal outcome increased to 4.7 (95% CI: 3.3-24.9), and patients with multiple organ failure had a 7.5-fold increase (95% CI: 2.3-25.2) for risk of death. Survivors demonstrated a more pronounced improvement in oxygenation ( p<0.05) and CO(2) removal ( p<0.05) than non-survivors.
CONCLUSIONS: Advanced treatment of ARDS including ECMO represents a therapeutic option if none of the currently considered contraindications are present. An improvement in gas exchange parameters, but not a defined value per se may be useful as a prognostic factor for favourable outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999396     DOI: 10.1007/s00101-004-0653-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  43 in total

1.  The necessity of performing transesophageal echocardiography in patients with acute respiratory distress syndrome.

Authors:  F Falter; R Kuhlen; U Janssens; M Max; E Walbert; R Rossaint
Journal:  Intensive Care Med       Date:  1999-06       Impact factor: 17.440

Review 2.  Treatment of ARDS.

Authors:  R G Brower; L B Ware; Y Berthiaume; M A Matthay
Journal:  Chest       Date:  2001-10       Impact factor: 9.410

3.  Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes.

Authors:  Peter Q Eichacker; Eric P Gerstenberger; Steven M Banks; Xizhong Cui; Charles Natanson
Journal:  Am J Respir Crit Care Med       Date:  2002-08-28       Impact factor: 21.405

4.  Impact of randomized trial results on acute lung injury ventilator therapy in teaching hospitals.

Authors:  Craig R Weinert; Cynthia R Gross; William A Marinelli
Journal:  Am J Respir Crit Care Med       Date:  2003-02-05       Impact factor: 21.405

Review 5.  Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R LeGall; A Morris; R Spragg
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

6.  Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.

Authors:  V M Ranieri; P M Suter; C Tortorella; R De Tullio; J M Dayer; A Brienza; F Bruno; A S Slutsky
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

7.  Pressure-time curve predicts minimally injurious ventilatory strategy in an isolated rat lung model.

Authors:  V M Ranieri; H Zhang; L Mascia; M Aubin; C Y Lin; J B Mullen; S Grasso; M Binnie; G A Volgyesi; P Eng; A S Slutsky
Journal:  Anesthesiology       Date:  2000-11       Impact factor: 7.892

8.  Conventional mechanical ventilation is associated with bronchoalveolar lavage-induced activation of polymorphonuclear leukocytes: a possible mechanism to explain the systemic consequences of ventilator-induced lung injury in patients with ARDS.

Authors:  Haibo Zhang; Gregory P Downey; Peter M Suter; Arthur S Slutsky; V Marco Ranieri
Journal:  Anesthesiology       Date:  2002-12       Impact factor: 7.892

9.  Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome.

Authors:  A H Morris; C J Wallace; R L Menlove; T P Clemmer; J F Orme; L K Weaver; N C Dean; F Thomas; T D East; N L Pace; M R Suchyta; E Beck; M Bombino; D F Sittig; S Böhm; B Hoffmann; H Becks; S Butler; J Pearl; B Rasmusson
Journal:  Am J Respir Crit Care Med       Date:  1994-02       Impact factor: 21.405

10.  Extracorporeal gas exchange with the DeltaStream rotary blood pump in experimental lung injury.

Authors:  Rolf Dembinski; Rüdger Kopp; Dietrich Henzler; Nadine Hochhausen; Nicole Oslender; Martin Max; Rolf Rossaint; Ralf Kuhlen
Journal:  Artif Organs       Date:  2003-06       Impact factor: 3.094

View more
  3 in total

Review 1.  [Extracorporeal membrane oxygenation and severe traumatic brain injury. Is the ECMO-therapy in traumatic lung failure and severe traumatic brain injury really contraindicated?].

Authors:  R M Muellenbach; A Redel; J Küstermann; A Brack; A Gorski; T Rösner; N Roewer; T Wurmb
Journal:  Anaesthesist       Date:  2011-03-16       Impact factor: 1.041

2.  Outcome of acute respiratory distress syndrome in university and non-university hospitals in Germany.

Authors:  Konstantinos Raymondos; Tamme Dirks; Michael Quintel; Ulrich Molitoris; Jörg Ahrens; Thorben Dieck; Kai Johanning; Dietrich Henzler; Rolf Rossaint; Christian Putensen; Hermann Wrigge; Ralph Wittich; Maximilian Ragaller; Thomas Bein; Martin Beiderlinden; Maxi Sanmann; Christian Rabe; Jörn Schlechtweg; Monika Holler; Fernando Frutos-Vivar; Andres Esteban; Hartmut Hecker; Simone Rosseau; Vera von Dossow; Claudia Spies; Tobias Welte; Siegfried Piepenbrock; Steffen Weber-Carstens
Journal:  Crit Care       Date:  2017-05-30       Impact factor: 9.097

3.  Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada.

Authors:  Darren H Freed; Dietrich Henzler; Chris W White; Robert Fowler; Ryan Zarychanski; Jamie Hutchison; Rakesh C Arora; Rizwan A Manji; Jean-Francois Legare; Tanya Drews; Stasa Veroukis; Murray Kesselman; Anne-Marie Guerguerian; Anand Kumar
Journal:  Can J Anaesth       Date:  2010-01-16       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.